Antifungal agents for common paediatric infections;Les antifongiques contre les infections pédiatriques courantes

Paediatrics and Child Health

Volumn 5, Issue 8, 2000, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; CANDISTATIN; CLOTRIMAZOLE; CRYSTAL VIOLET; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; MICOZOLE; MYCLO DERM; NYSTATIN; SELENIUM SULFIDE; TERBINAFINE; VERSEL;

CHILD; CLINICAL TRIAL; DIAPER DERMATITIS; DRUG COST; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INFECTION; MUCOCUTANEOUS CANDIDIASIS; REVIEW; THRUSH; TINEA CAPITIS; TINEA CORPORIS; TINEA PEDIS; TINEA VERSICOLOR;

EID: 0034486087     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/5.8.477     Document Type: Review

References (44)

1. Incidence and pathogenesis of neonatal candidiasis
2. Cutaneous candidiasis in early infancy and childhood
3. Thrush napkin rashes
4. The treatment of thrush with gentian violet
5. Therapeutic evaluation of nystatin and amphotericin in oral moniliasis in infants
6. Comparison of ketoconazole suspension and nystatin in the treatment of newborns and infants with oral candidiosis
7. Treatment of oropharyngeal candidiasis in immunocompetent infants: A randomized multicenter study of miconazole gel vs nystatin suspension. The Antifungals Study Group
8. A new approach to the use of antifungal agents in children with persistent oral candidiasis
9. Treatment of thrush
10. Amphotericin B oral suspension in the treatment of thrush
11. Napkin (diaper) dermatitis and gastrointestinal carriage of Candida albicans
12. Alimentary Candida alibicans and napkin rashes
13. Treatment of candidal diaper dermatitis: A double-blind placebo-controlled comparison of topical nystatin with topical plus oral nystatin
14. Malassezia species
15. An overview of topical antifungal therapy in dermatomycoses. A North American perspective
16. Ketoconazole 2% shampoo in the treatment of tinea versicolor: A multicenter, randomized, double-blind, placebo controlled trial
17. Dermatophytes and other superficial fungi
18. Onychomycosis in children: Prevalence and treatment strategies
19. Terbibafine verus itraconazole: A controlled clinical comparison in onychomycosis of toenails
20. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: A double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day
21. Comparison of ketoconazole and griseofulvin for the treatment of tinea capitis in childhood: A preliminary study
22. Treating tinea capitis: Should ketoconazole replace griseofulvin?
23. Epidemiology and treatment of tinea capitis: Ketoconazole vs griseofulvin
24. Double-blind study of ketoconazole and griseofulvin in dermatophytoses
25. Fluconazole: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses
26. Treatment of kerion with fluconazole
27. Fluconazole for the treatment of tinea capitis in children
28. Itraconazole vs griseofulvin in the treatment of tinea capitis: A double-blind randomized study in children
29. Itraconazole in the treatment of tinea capitis
30. Successful treatment of griseofulvin-resistant tinea capitis in infants
31. Tinea capitis: Itraconazole in Trichophyton tonsurans infection
32. Treatment of tinea capitis with itraconazole
33. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250mg terbinafine orally once per day for four weeks
34. The mechanism of action of terbinafine
35. An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis
36. Pilot study of terbinafine in children suffering from tinea capitis: Evaluation of efficacy, safety and pharmacokinetics
37. A randomized double-blind trial of the efficacy and tolerability of terbinafine once daily compared to griseofulvin once daily in treatment of tinea capitis
38. A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis
39. Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis
40. Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children
41. Selenium sulfide: Adjunctive therapy for tinea capitis
42. Comparison of 1% and 2.5% selenium sulfide in the treatment of tinea capitis
43. Systemic antifungal agents. Drug interactions of clinical significance
44. Dermatophyte infections in children